Vilpert Sarah, Borrat-Besson Carmen, Maurer Jürgen, Borasio Gian Domenico
Faculty of Biology and Medicine (FBM), University of Lausanne, Switzerland / Swiss Centre of Expertise in the Social Sciences (FORS), University of Lausanne, Switzerland.
Swiss Centre of Expertise in the Social Sciences (FORS), University of Lausanne, Switzerland.
Swiss Med Wkly. 2018 Jul 29;148:w14642. doi: 10.4414/smw.2018.14642. eCollection 2018 Jul 16.
Advance directives enable people to describe their preferences for medical treatment (living will) and/or to appoint a healthcare proxy who may decide on their behalf should they lose decision-making capacity. Advance directives are potentially important in determining the course of end-of-life care, as deaths are frequently preceded by end-of-life treatment decisions, which often require someone to make decisions on the patient's behalf. Switzerland introduced legally binding advance directives through its new child and adult protection law of 2013. But there is still no comprehensive evidence on older persons' awareness, attitudes and behaviours with regard to advance directives in Switzerland.
Our study aimed to assess levels of awareness, approval and completion of advance directives, as well as their respective associations with sociodemographic characteristics in the Swiss population aged 55 and older. Our study was cross-sectional and used data from the Survey of Health, Ageing and Retirement in Europe (SHARE), which included a special module on end-of-life issues in wave 6 (2015) in Switzerland (n = 2085).
Two years after the introduction of advance directives in Switzerland, 78.7% of adults aged 55 years and older had heard of them prior to the survey and 24% reported that they had completed one. Awareness of advance directives was higher in the German-speaking part of Switzerland (91%) than in the Italian- (57.1%) and French-speaking (43.3%) regions (p <0.001). Advance directive completion also differed significantly between the German- (28.7%), French- (10.3%) and Italian-speaking (17.9%) regions of Switzerland (p <0.001). Overall, 76.7% of Swiss adults aged 55 and older generally approved of advance directives, i.e., they either reported having already completed one or were planning to do so in the future. Of those who had not yet completed an advance directive, 32.9% believed that it was still "too early" for them to do so and 30.1% believed that they would not need one. Levels of awareness, approval and completion of advance directives also varied significantly by sex, age, education level and household composition.
Our results show some potential for improvement in levels of advance directive awareness and, especially, completion among older adults, notably in the French- and Italian-speaking Switzerland. In view of the generally high levels of approval of advance directives, our findings point to important barriers to their completion by older persons that should be addressed by policy makers in order to ensure an effective translation of individual intentions to complete an advance directive sometime in the future into concrete and timely actions toward this end.
预立医疗指示使人们能够描述自己对医疗治疗的偏好(生前遗嘱)和/或指定一名医疗代理人,在其丧失决策能力时代表他们做出决定。预立医疗指示在确定临终护理的过程中可能具有重要意义,因为死亡之前往往会做出临终治疗决定,而这通常需要有人代表患者做出决定。瑞士通过其2013年新的儿童和成人保护法引入了具有法律约束力的预立医疗指示。但在瑞士,关于老年人对预立医疗指示的知晓情况、态度和行为,仍缺乏全面的证据。
我们的研究旨在评估瑞士55岁及以上人群对预立医疗指示的知晓程度、认可程度和完成情况,以及它们与社会人口学特征的各自关联。我们的研究是横断面研究,使用了欧洲健康、老龄化和退休调查(SHARE)的数据,其中包括在瑞士第6轮(2015年)关于临终问题的一个特别模块(n = 2085)。
在瑞士引入预立医疗指示两年后,55岁及以上的成年人中有78.7%在调查前听说过它们,24%报告说他们已经完成了一份。瑞士讲德语地区对预立医疗指示的知晓率(91%)高于讲意大利语(57.1%)和法语(43.3%)的地区(p <0.001)。瑞士讲德语(28.7%)、法语(10.3%)和意大利语(17.9%)的地区在预立医疗指示的完成情况上也存在显著差异(p <0.001)。总体而言,76.7%的瑞士55岁及以上成年人普遍认可预立医疗指示,即他们要么报告已经完成了一份,要么计划在未来完成。在那些尚未完成预立医疗指示的人中,32.9%认为对他们来说现在这样做“还为时过早”,30.1%认为他们不需要。预立医疗指示的知晓程度、认可程度和完成情况在性别、年龄、教育水平和家庭构成方面也有显著差异。
我们的结果表明,在提高老年人对预立医疗指示的知晓程度方面,尤其是在完成情况方面,仍有一些改进的潜力,特别是在瑞士讲法语和意大利语的地区。鉴于对预立医疗指示的普遍高度认可,我们的研究结果指出了老年人完成预立医疗指示的重要障碍,政策制定者应加以解决,以确保将个人未来某个时候完成预立医疗指示的意图有效转化为为此目的的具体及时行动。